Black Pearl Extends Tender Offer for Selectis Health to August 17; 2.8M Shares Tendered
GBCS has more than doubled off its 52-week low of $0.405.
Summary
Black Pearl extended its $5.75/share tender offer for Selectis Health to August 17, with 2.8 million shares already tendered—well above the 70% minimum condition. The deal is on track to close.
Key Events · M&A and Partnerships · GBCS
-
Tender Offer Extended to August 17
Black Pearl extended the expiration of its $5.75 per share cash tender offer for all outstanding Selectis Health shares from August 10 to August 17, 2026.
-
2.8 Million Shares Tendered
As of August 10, 2,807,869 shares had been validly tendered and not withdrawn, representing approximately 91% of the estimated 3.07 million shares outstanding.
-
Minimum Tender Condition Met
The offer requires at least 70% of outstanding shares to be tendered; with 91% already tendered, this condition is satisfied.
-
Deal Closing Imminent
The extension likely allows time to satisfy remaining customary closing conditions; the transaction is not subject to financing contingencies.
Analysis · GBCS · Real Estate & Construction
The $5.75 per share cash tender offer for Selectis Health has been extended by one week, now expiring August 17, 2026. By the original deadline, 2,807,869 shares had been tendered—roughly 91% of the 3,067,000 shares outstanding, based on the company's market cap and stock price. With the minimum condition of 70% comfortably met, the extension signals that the parties are finalizing closing conditions, and the deal is likely to close shortly after the new expiration.
At the time of this filing, GBCS was trading at $5.65 on OTC in the Real Estate & Construction sector, with a market capitalization of approximately $17.3M. The 52-week trading range was $0.41 to $5.65. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.